Is 5-alpha reductase inhibitor capable to alter the natural history of slightly enlarged prostate? a prospective multi center study

Is 5-alpha reductase inhibitor capable to alter the natural history of slightly enlarged prostate? a prospective multi center study - Five-alpha reductase inhibitor for slightly enlarged prostate with LUTS

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027832

Enrollment

Registered

2017-06-20

Start date

2017-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: patients newly diagnosed as BPH with IPSS eight points or greater, prostate volume less than 30 ml and Group 3 by transrectal ultrasound

Exclusion criteria

Exclusion criteria: use of drugs affecting prostate volume such as antiandrogenic agent

Design outcomes

Primary

Measure	Time frame
change of prostate volume and adherence to prescribed drugs	—

Secondary

Measure	Time frame
change of LUTS	—

Countries

Japan

Contacts

Public ContactKou Kobayashi

Sapporo medical university school of medicine the department of urology

ffukuta@sapmed.ac.jp011-611-2111

Outcome results